Dr. Clay Siegall is one of the respected scientists in the United States. He currently works as the chairman and president of the biggest biotechnology company in the US, known as Seattle Genetics. The biotechnology company specializes in the commercialization and development of antibody therapies for cancer treatment. As the president of Seattle Genetics, Clay Siegall has played a fundamental role in the development of antibody drug conjugates. The first ADC product from the firm, known as ADCETRIS, was approved by FDA in the year 2011.
Seattle Genetics has also partnered with Takeda Pharmaceutical Company to market ADCETRIS to more than sixty nations. At the moment, the drug has won the hearts of many because of its ability to cure cancer. Many individuals have benefited from the product. As the chairman of the board at Seattle Genetics, Clay Siegall is responsible for the capital raising activities. Just recently, the private biotechnology company announced to the world that it had successfully managed to raise over one billion dollars in private and public finances. The money will be used to advance cancer treatment. The money raised will also be used to increase the employees working in the institution. In five years, the company will have increased cancer therapies for different types of cancers.
Why Dr. Clay Siegall started Seattle Genetics
Dr. Clay Siegall chose to establish Seattle Genetics to help individuals living with cancer. The scientist watched as his father suffered and finally lose his life due to the dangerous diseases. During the entire process, the scientist realized that there were very few cancer treatment options for individuals with the disease. He also realized that the form of therapy used on patients was not safe, and patients better and more efficient drugs. For the last thirty years, Clay Siegall has been focusing on making his dream to come true.
Clay Siegall Background
Before starting the biotechnology firm, Siegall was serving at Bristol Meter and several other research institutes. His contributions in these companies is recognized up to date. Clay studied Zoology at the University of Maryland. He later went for masters in Genetics in one of the prestigious universities in the world.